Insider filing · CORT
Joseph K Belanoff
Chief Executive Officer
profile →
Corcept Therapeutics Incorporated
CORT · Healthcare · 103 filings in 24 months
ticker →
Joseph K Belanoff sold $2.8M of Corcept Therapeutics Incorporated (CORT)
Executed Sep 2 2025, disclosed Sep 4 2025, 2 days later.
Value, as filed
$2.8M
39,300 sh × $70.52
Executed
Sep 2 2025
the trade date, as filed
Disclosed
Sep 4 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JBJoseph K Belanoff (Chief Executive Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Corcept Therapeutics Incorporated (CORT). The largest single filing was $3.4M of CORT (40,000 sh across 3 lots, as filed), executed Oct 1 2025.
The name
CORTHealthcare · Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe end…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Joseph K Belanoff in CORT
CORTSALE
Corcept Therapeutics Incorporated
$895K12,837 sh × $69.74
Exec Jun 1
Filed Jun 2 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $2.0M
40,000 sh × $50.10
Exec May 1
Filed May 5 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $1.3M
26,198 sh × $50.07
Exec Mar 25
Filed Mar 27 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $3.2M
40,000 sh × $79.77
Exec Dec 1 2025
Filed Dec 3 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $3.0M
40,000 sh across 4 lots
Exec Nov 3 2025
Filed Nov 5 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $3.4M
40,000 sh across 3 lots
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $2.7M
40,000 sh across 3 lots
Exec Aug 1 2025
Filed Aug 5 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $3.3M
40,000 sh across 8 lots
Exec Jun 2 2025
Filed Jun 4 2025 · 5:30 PM ET